| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.40B | +17.5% |
| Cost of Revenue | $461.2M | +4.9% |
| Gross Profit | $942.4M | +24.8% |
| R&D Expense | $89.8M | -5.3% |
| SG&A Expense | $663.4M | +15.6% |
| Operating Income | $189.2M | +1939.5% |
| Pre-tax Income | $205.1M | +882.9% |
| Income Tax | $27.4M | +300.1% |
| Net Income | $177.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $186.9M | -42.4% |
| Accounts Receivable | $190.0M | +13.3% |
| Inventory | $431.5M | +6.1% |
| Current Assets | $1.22B | +27.9% |
| Total Assets | $1.83B | +19.1% |
| Current Liabilities | $183.1M | +15.7% |
| Total Liabilities | $398.9M | +4.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $238.7M | +41.7% |
| Capital Expenditures | $63.7M | +200.9% |
| Investing Cash Flow | -$404.6M | -621.2% |
| Financing Cash Flow | $26.5M | +130.5% |
| Free Cash Flow | $174.9M | +18.8% |
| +1168.1% |
| EPS (Basic) | $4.57 | +1169.4% |
| EPS (Diluted) | $4.52 | +1155.6% |
| Stockholders' Equity |
| $1.43B |
| +24.0% |